New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

A major new analysis from REBOOT (Treatment with Beta-blockers after Myocardial Infarction without Reduced Ejection Fraction) clinical trial has revealed important sex-specific differences in the effe...

Read more

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of the ...

Read more

La dieta mediterránea hipocalórica combinada con actividad física reduce el riesgo de desarrollar diabetes

by Universitat Rovira i Virgili

La investigación enmarcada en el estudio PREDIMED-Plus, coordinado por el investigador Jordi Salas-Salvadó (URV-IISPV), ha seguido 4.746 personas con sobrepeso o obesidad y síndrome metabólica dur...

Read more

Respiratory symptoms during the stable phase of bronchiectasis are a key factor in prognosis and response to treatment

by Fundació Clínic per a la Recerca Biomèdica

Researchers from the Clinic-IDIBAPS lead an international study, published in The Lancet Respiratory Medicine, which demonstrates the importance of respiratory symptoms in prognosis and treatment resp...

Read more

WLCC2025: An innovative targeted therapy shows promising results in the treatment of lung cancer with ROS1 gene alterations

by VHIO

Results from the international Phase 1/2 clinical trial ARROS-1 show promising outcomes with zidesamtinib, a novel ROS1 selective inhibitor under investigation, in patients with advanced non-small cel...

Read more

Pharmacokinetics and Pharmacodynamics (PK/PD) Studies in Drug Development: From ADME Principles to Translational Applications

by AMSbiopharma

Pharmacokinetics describes the journey of a drug through de body, covering absorption, distribution, metabolism, and excretion (ADME). This trajectory determines the concentration of the drug in the b...

Read more

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need

by Ysios Capital

Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension

Read more

CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X Syndrome with EIC Accelerator Support

by Parc Científic de Barcelona

CONNECTA Therapeutics, a clinical-stage biotech company located at the Barcelona Science Park (PCB), which leads the development of first-in-class neuroplasticity modulators to address unmet medical n...

Read more

INCLIVA reúne a personal investigador, profesionales clínicos y pacientes de distrofia miotónica tipo 1 (DM1) para abordar la situación de las investigaciones y retos en relación con esta enfermedad

by INCLIVA

El objetivo de la jornada era presentar DM1-Hub, un registro nacional de DM1 en el que participan 50 hospitales de 8 comunidades autónomas con datos clínicos, de estilo de vida, neuropsicológicos, ...

Read more

ORYZON strengthens patent portfolio for iadademstat and vafidemstat with new Decisions to Grant

by Oryzon Genomics

Oryzon Genomics, S.A. a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that it continues to expand its patent portfolio for iadademstat and vafidemstat,...

Read more

VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment

by Ysios Capital

Financiación completa del ensayo de fase III del VMX-C001, desarrollo del producto en fase avanzada, fabricación y actividades previas al lanzamiento.

Read more

An Aragonese study suggests that a milk protein could have intestinal benefits.

by Universidad de Zaragoza

The results obtained support the thesis that lactoferrin protects against intestinal inflammation by modulating serotonin.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream